Journey of Neuome
ABOUT
NEUOME
Neuome Technologies is a trailblazing biotech startup at the intersection of science
and innovation, committed to transforming healthcare through advanced life sciences
research and sustainable solutions. At Neuome Technologies, we are redefining the
future of diagnostics through the convergence of cutting-edge science and
innovation. As a forward-thinking biotech startup, our mission is to develop
disruptive diagnostic solutions that are precise but also accessible, sustainable,
and scalable. By integrating advanced biotechnology, life sciences, and
bioinformatics, we address some of the most pressing challenges in healthcare
today.


VISION
To become a global leader in biotechnology innovation by delivering cutting-edge, sustainable solutions that transform the healthcare landscape and improve lives worldwide.

MISSION
Our mission is to harness the power of scientific discovery and technological advancement to create solutions that bridge the gap between research and real-world healthcare needs.
Message From the
Founder & CEO
At Neuome Technologies, we believe in the power of disruptive innovation to
transform healthcare. We aim to bridge the gap between groundbreaking scientific
discoveries and real-world applications that improve lives. As the Founder and CEO,
my mission is to drive forward revolutionary, accessible, sustainable, and impactful
technologies.
As the Founder and CEO of Neuome, I am proud of the strides we’ve made in pioneering technologies like instaPRESERVE, which is transforming biospecimen handling by eliminating cold chain requirements, and InstaDetect, our ultrasensitive pathogen diagnostic platform that brings rapid, point-of-care solutions to the forefront. These innovations reflect our commitment to delivering advanced tools that improve research and clinical outcomes while reducing costs and inefficiencies.
At the heart of Neuome lies a passionate team of scientists, innovators, and thought leaders who believe in the transformative power of science. Together, we are building a future where healthcare is more precise, more sustainable, and more accessible.
As the Founder and CEO of Neuome, I am proud of the strides we’ve made in pioneering technologies like instaPRESERVE, which is transforming biospecimen handling by eliminating cold chain requirements, and InstaDetect, our ultrasensitive pathogen diagnostic platform that brings rapid, point-of-care solutions to the forefront. These innovations reflect our commitment to delivering advanced tools that improve research and clinical outcomes while reducing costs and inefficiencies.
At the heart of Neuome lies a passionate team of scientists, innovators, and thought leaders who believe in the transformative power of science. Together, we are building a future where healthcare is more precise, more sustainable, and more accessible.

Thank you for your interest in Neuome Technologies. I invite you to explore our work,
vision, and passion for creating a healthier tomorrow.
Warm regards,
Dr. Rajani Kanth Vangala
Founder & CEO
Neuome Technologies Private Limited


OUR JOURNEY

2020
Neuome registered in 2020, just before the onset of Covid-19

Establishment of InstaDetect Platform for the Peptide based assay for covid detection

Receiving ICMR Approval for the assay with 98% sensitivity

Establishment of instaPRESERVE platform and receiving BIRAC BIG grant for its development

2024
instaPRESERVE launched by BIRAC IT, BT Government of INDIA